JANX icon

Janux Therapeutics

50 hedge funds and large institutions have $381M invested in Janux Therapeutics in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

2% less capital invested

Capital invested by funds: $388M → $381M (-$7.13M)

6.16% less ownership

Funds ownership: 75.66%69.5% (-6.2%)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
50
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$804K
Puts
$21K
Net Calls
Net Calls Change

Top Buyers

1 +$3.97M
2 +$1.39M
3 +$757K
4
Millennium Management
Millennium Management
New York
+$526K
5
E
Ergoteles
New York
+$416K

Top Sellers

1 -$27.4M
2 -$8.45M
3 -$1.94M
4
Morgan Stanley
Morgan Stanley
New York
-$1.63M
5
Cerity Partners
Cerity Partners
New York
-$1.43M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$114M
2
$73.8M
3
$37.4M
4
$24.4M
5
$24.2M
6
$19.4M
7
$18.7M
8
$14.5M
9
$9.94M
10
$9.23M
11
$6.66M
12
$5.88M
13
$4.75M
14
$4.47M
15
$3.73M
16
$1.84M
17
$1.37M
18
$799K
19
$757K
20
$705K
21
$668K
22
$628K
23
$526K
24
$416K
25
$338K